Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center discusses the impact of the AIM2CERV study on patients with cervical cancer and on clinical practice. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
AIM2CERV Based on Data that Shows Promise in Patients with Cervical Cancer
